IBC0966
/ SunHo BioPharma, ImmuneOnco Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 10, 2023
Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1/2 | N=228 | Recruiting | Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Breast Cancer • Head and Neck Cancer • Hematological Malignancies • HER2 Breast Cancer • Hormone Receptor Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Peripheral T-cell Lymphoma • Solid Tumor • Squamous Cell Carcinoma of Head and Neck • Triple Negative Breast Cancer • ER • HER-2 • PD-L1 • PGR
July 28, 2021
Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1/2; N=228; Not yet recruiting; Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd.
New P1/2 trial • Breast Cancer • Head and Neck Cancer • Hematological Malignancies • HER2 Breast Cancer • Hormone Receptor Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Peripheral T-cell Lymphoma • Squamous Cell Carcinoma of Head and Neck • Triple Negative Breast Cancer • ER • HER-2 • PD-L1 • PGR
1 to 2
Of
2
Go to page
1